Enabling the Future of Non-Invasive Chronic Condition Monitoring
ABSTRACT
Since the 1990s, people have been searching for a non-invasive way to monitor chronic conditions. Now, with the development of at-home testing and telemedicine markets, this desire has grown even stronger.
One promising approach is to measure Volatile Organic Compounds (VOCs) in breath and sweat, which has been shown to correlate with many diseases such as diabetes, asthma, COPD, obstructive sleep apnea syndrome, pulmonary arterial hypertension, cystic fibrosis, upper respiratory tract infection, sepsis, NAFLD and NASH.
A non-invasive, user-friendly, and miniaturized VOC breath analyzer capable of monitoring several chronic conditions would be a major breakthrough, revolutionizing how chronic condition monitoring is performed. Single application devices already exist on the market using MOx gas sensors, but technology could be further improved to enable multiple applications to be integrated into a single device.
To fully realize the potential of at-home testing and telemedicine, the sensors and MedTech industries must collaborate to produce multi-analyte sensors.
BIOGRAPHY
Bruno Thuillier is a technologist, inventor, entrepreneur, and innovator and is serving as CTO of BOYDSense which he founded in 2015.
Following his studies in Physics, Bruno explored convergent, rapidly developing technologies and their potential in wireless industry. Bruno was Vice President of Siemens Mobile Phone R&D at Global Fortune 100 company Siemens (Xetra: SIE). He assembled talented and successful teams in Germany, Denmark and US, and developed breakthrough mobile devices.
With over 30 years of experience in Tech and MedTech, Bruno has served as CTO of Sensitive Object, a startup acquired in 2010 by TE Connectivity (NYSE: TEL). He developed a touch sensor technology that works on all type of surfaces and materials, enabling the deployment of new user interfaces for harsh environments in various industries, such as medical industry.
Bruno founded BOYDSense in 2015, an award-winning startup with R&D in France and the U.S. BOYDSense is a pioneer in the development of non-invasive breath analysis solutions for monitoring and detection of different markers. BOYDSense is currently developing its first product, a miniaturized breath analyzer for monitoring glucose concentration. It detects selected volatile organic compounds in breath. The solution will be non-invasive, gentle, affordable, and produces significantly less waste compared to existing finger stick blood glucose or continuous glucose monitors.
Bruno is a senior member of the Institute of Electrical and Electronics Engineers (IEEE) and an inventor on several patents.